Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
FierceBiotech
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them. Fierce Biotech covers the biopharma waterfront, from drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Biotech team produces special reports that take stock of the industry's products and finances, and shed new light on industry trends.
Visit website: https://www.fiercebiotech.com/
Details last updated 08-Feb-2019
People at FierceBiotech
Helen Floersh
Writer at Fierce Biotech, covering developments in basic science research and early-stage drug development.
Articles sourced from FierceBiotech
Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Splicebio raises $135m to advance gene therapy for eye disease
FierceBiotech - 11-Jun-2025SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials
FierceBiotech - 27-May-2025Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Lilly bets big on AI-discovered ALS drug in $415m deal
FierceBiotech - 06-May-2025AI-powered therapy offers new hope for ALS as early trials approach
Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
New UK clinical trial laws aim for faster research approvals
FierceBiotech - 14-Apr-2025New funding and better access are part of efforts to make Britain leader in medical innovation
Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025Backed by Nobel science, the Alphabet spinout speeds up AI drug development
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025Verve regains full rights to its liver disease program as it moves forward independently
Gene therapy restores hearing in children with rare deafness
FierceBiotech - 24-Feb-2025Regeneron’s DB-OTO offers new hope for genetic hearing loss
Cell therapy breakthrough offers new hope for type 1 diabetes
FierceBiotech - 08-Jan-2025Early trial results show promise for insulin production without immune suppression
ALS drug trials face setbacks but offer glimmers of hope
FierceBiotech - 07-Jan-2025Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Basecamp scales up AI-driven gene therapy
FierceBiotech - 06-Jan-2025Basecamp expands AI and genetic tools to create fast, programmable gene therapies
Khondrion's sonlicromanol faces setback in phase 2 trial, but holds onto hope
FierceBiotech - 22-Nov-2024Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
AI-developed drug improves lung function in idiopathic pulmonary fibrosis
FierceBiotech - 12-Nov-2024Drug improved chronic cough symptoms, contributing to a better quality of life\
Horizon Surgical raises $30M to enhance robotic cataract surgery
FierceBiotech - 21-Oct-2024Their Polaris system aims to improve cataract removal precision and consistency
Gilead strikes $35m AI drug discovery deal with Genesis
FierceBiotech - 10-Sep-2024The biotech’s advanced AI platform aims to unlock new treatments for challenging drug targets
Bioage prepares for IPO, targets obesity with new drug trials
FierceBiotech - 04-Sep-2024Biotech firm Bioage plans public debut as it advances promising obesity treatments
Display all articles
